| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $56.6M | -1.1% | -3.3% |
| Cost of Revenue | $33.4M | +7.4% | +3.1% |
| Gross Profit | $23.2M | -11.2% | -11.3% |
| R&D Expense | $1.3M | +9.0% | -31.6% |
| SG&A Expense | $8.0M | -5.8% | -10.1% |
| Operating Income | -$3.9M | -287.1% | -1391.4% |
| Pre-tax Income | -$4.1M | -296.2% | -1893.8% |
| Income Tax | $1K | — | -98.3% |
| Net Income | -$4.1M | -296.3% | -2510.1% |
| EPS (Basic) | -$0.32 | -300.0% | -3300.0% |
| EPS (Diluted) | -$0.32 | -300.0% | -3300.0% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.4M | +234.1% | -39.1% |
| Accounts Receivable | $32.9M | -18.3% | +4.0% |
| Inventory | $110.2M | -11.1% | -4.8% |
| Current Assets | $158.6M | -7.4% | -5.6% |
| Total Assets | $225.0M | -6.6% | -8.5% |
| Current Liabilities | $28.1M |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.1M | — | — |
| Capital Expenditures | $2.0M | — | — |
| Investing Cash Flow | -$2.6M | — | — |
| Financing Cash Flow | -$5.4M | — | — |
| Free Cash Flow | -$7.1M | — | — |
| -19.6% |
| Total Liabilities | $59.3M | -15.9% | -11.7% |
| Stockholders' Equity | $165.7M | -2.8% | -7.3% |